Journal
EUROPEAN RADIOLOGY
Volume 31, Issue 11, Pages 8714-8724Publisher
SPRINGER
DOI: 10.1007/s00330-021-07956-0
Keywords
Multimodal imaging; Positron emission tomography; Tomography; X-ray; Radionuclide imaging; Breast neoplasms
Funding
- Projekt DEAL
- Deutsche Forschungsgemeinschaft (DFG), the German Research Foundation [BU3075/2-1]
- Deutsche Forschungsgemeinschaft (DFG)
Ask authors/readers for more resources
This study compared the diagnostic performance of different imaging techniques in detecting bone metastases in patients with primary breast cancer. [F-18]FDG PET/MRI and MRI alone showed significantly higher sensitivity and specificity than CT and bone scintigraphy; CT and bone scintigraphy had lower sensitivity in detecting bone metastases and were prone to false-positive results.
Objectives To compare the diagnostic performance of [F-18]FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients. Material and methods A cohort of 154 therapy-naive patients with newly diagnosed, histopathologically proven breast cancer was enrolled in this study prospectively. All patients underwent a whole-body [F-18]FDG PET/MRI, computed tomography (CT) scan, and a bone scintigraphy prior to therapy. All datasets were evaluated regarding the presence of bone metastases. McNemar chi(2) test was performed to compare sensitivity and specificity between the modalities. Results Forty-one bone metastases were present in 7/154 patients (4.5%). Both [F-18]FDG PET/MRI and MRI alone were able to detect all of the patients with histopathologically proven bone metastases (sensitivity 100%; specificity 100%) and did not miss any of the 41 malignant lesions (sensitivity 100%). CT detected 5/7 patients (sensitivity 71.4%; specificity 98.6%) and 23/41 lesions (sensitivity 56.1%). Bone scintigraphy detected only 2/7 patients (sensitivity 28.6%) and 15/41 lesions (sensitivity 36.6%). Furthermore, CT and scintigraphy led to false-positive findings of bone metastases in 2 patients and in 1 patient, respectively. The sensitivity of PET/MRI and MRI alone was significantly better compared with CT (p < 0.01, difference 43.9%) and bone scintigraphy (p < 0.01, difference 63.4%). Conclusion [F-18]FDG PET/MRI and MRI are significantly better than CT or bone scintigraphy for the detection of bone metastases in patients with newly diagnosed breast cancer. Both CT and bone scintigraphy show a substantially limited sensitivity in detection of bone metastases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available